Valo

Valo is a biotech company designing the next generation of medicines using cutting-edge laboratory science, large-scale biological knowledge, real world data, and machine learning. Our team brings together experts in the fields ranging from medicinal chemistry to software engineering to biostatistics in order better identify and develop new therapies for neurodegenerative diseases, cardiovascular diseases, and cancers. Valo was founded by Flagship Pioneering, who’s other companies include Modern Therapeutics and Indigo Agriculture, and recently raised a $190 million Series B